Натализумаб в терапии рассеянного склероза. Опыт применения в Московском городском центре рассеянного склероза
https://doi.org/10.21518/2079-701X-2014-10-52-55
Аннотация
Об авторах
Е. В. ПоповаРоссия
А. Н. Бойко
Россия
М. В. Давыдовская
Россия
О. В. Бойко
Россия
Н. В. Хачанова
Россия
Список литературы
1. Havrdova E, Galetta S, Hutchinson M et al. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study Lancet Neurol, 2009, 8(3): 254-60.
2. Munschauer F, Giovannoni G, Lublin F et al. Natalizumab significantly increases the cumulative probability of sustained improvement in physical disability. Presentation at WCTRIMS. Montreal, 2008.
3. O'Connor PW et al. Return of Disease Activity After Cessation of Natalizumab Therapy in Patients with Multiple Sclerosis, Presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Dusseldorf, Germany, September 9-12, 2009.
4. Pucci E, Giuliani G, Solari A et al. Natalizumab for relapsing remitting multiple sclerosis. Cochrane Database of Systematic Reviews, 2011 Oct 5 (10): CD007621.
5. Stuve O, Cravens PD, Frohman EM et al. Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology, 2009, 72 (5): 396-401.
6. Sorensen PS, Bertolotto A, Edan G et al. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler, 2012, 18 (2): 143-152.
7. Sormani MP, Stefano N. Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy J Neurol., 2014, 82: 1-2.
Рецензия
Для цитирования:
Попова Е.В., Бойко А.Н., Давыдовская М.В., Бойко О.В., Хачанова Н.В. Натализумаб в терапии рассеянного склероза. Опыт применения в Московском городском центре рассеянного склероза. Медицинский Совет. 2014;(10):52-55. https://doi.org/10.21518/2079-701X-2014-10-52-55
For citation:
Popova E.V., Boyko A.N., Davydovskaya M.V., Boyko O.V., Khachanova N.V. Natalizumab in the treatment of multiple sclerosis. Experience of the Moscow Multiple Sclerosis Center (MMSC). Meditsinskiy sovet = Medical Council. 2014;(10):52-55. (In Russ.) https://doi.org/10.21518/2079-701X-2014-10-52-55